← Open Payments lookup

CHING-SHIH HU: Open Payments

NPI 1336207216 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$951 in 42 payments from 12 companies in 2025. Trend: 2023 $950 · 2024 $710 · 2025 $951

Food & beverage: $951
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$332
Teva Pharmaceuticals USA, Inc.8$162
Otsuka America Pharmaceutical, Inc.5$120
E.R. Squibb & Sons, L.L.C.6$103
Alkermes, Inc.4$89
Vanda Pharmaceuticals Inc.1$34
Axsome Therapeutics, Inc.1$22
Otsuka Pharmaceutical Development & Commercialization, Inc.1$22
Braeburn Inc.1$21
ABBVIE INC.1$17

Products named: INGREZZA, COBENFY, REXULTI, AUSTEDO XR, UZEDY, ARISTADA, FANAPT, VIVITROL.

Industry payments across LA — which companies pay providers there.